Literature DB >> 2836255

Anal cancer in women.

F Holmes1, D Borek, M Owen-Kummer, R Hassanein, J Fishback, A Behbehani, A Baker, G Holmes.   

Abstract

We studied predisposing factors in 56 women with anal cancer, comparing them with 56 matched controls drawn from the population. A detailed pretested questionnaire was administered to each study subject in a structured interview and blood was drawn for detection of herpes simplex virus antibodies by radioimmunoassay. Pathologic material from cases was obtained and evidence of human papilloma virus infection was sought. By univariate analyses we found associations between anal cancer and positive herpes simplex virus 2 titer (p = 0.0017), cigarette smoking (p = 0.0028), previous positive or questionable cervical Papanicolaou smear (p = 0.0124), and increasing number of sexual partners (p = 0.0224). By the multivariate technique of logistic regression there were independent and significant associations with cigarette smoking (p = 0.0126), previous use of hemorrhoid preparations (p = 0.0149), and history of disturbed bowel habits for greater than 1 mo (p = 0.0273). Anal cancer in women is a rare disease associated with cigarette smoking and sexual experience. Its association with previous anorectal disease is unclear and deserving of further study.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2836255     DOI: 10.1016/0016-5085(88)90297-1

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  9 in total

1.  Elevated anal squamous cell carcinoma risk associated with benign inflammatory anal lesions.

Authors:  C Nordenvall; O Nyrén; W Ye
Journal:  Gut       Date:  2005-11-18       Impact factor: 23.059

Review 2.  Anal human papillomavirus and anal cancer.

Authors:  P Tilston
Journal:  J Clin Pathol       Date:  1997-08       Impact factor: 3.411

3.  The association between body mass index and anal canal human papillomavirus prevalence and persistence: the HIM study.

Authors:  Alan G Nyitray; Fen Peng; Rena S Day; Roberto J Carvalho Da Silva; Maria Luiza Baggio; Jorge Salmerón; Manuel Quiterio; Martha Abrahamsen; Eduardo Lazcano-Ponce; Luisa L Villa; Anna R Giuliano
Journal:  Hum Vaccin Immunother       Date:  2019-04-19       Impact factor: 3.452

4.  Gay and bisexual men's willingness to receive anal Papanicolaou testing.

Authors:  Alison C Reed; Paul L Reiter; Jennifer S Smith; Joel M Palefsky; Noel T Brewer
Journal:  Am J Public Health       Date:  2010-04-15       Impact factor: 9.308

5.  The treatment of squamous anal carcinoma: guidelines of the Italian Society of Colo-Rectal Surgery.

Authors:  I Giani; M Mistrangelo; C Fucini
Journal:  Tech Coloproctol       Date:  2012-11-10       Impact factor: 3.781

6.  Epidermoid carcinoma of the anal canal.

Authors:  Bruce W Robb; Matthew G Mutch
Journal:  Clin Colon Rectal Surg       Date:  2006-05

7.  Understanding the burden of human papillomavirus-associated anal cancers in the US.

Authors:  Djenaba A Joseph; Jacqueline W Miller; Xiaocheng Wu; Vivien W Chen; Cyllene R Morris; Marc T Goodman; Jose M Villalon-Gomez; Melanie A Williams; Rosemary D Cress
Journal:  Cancer       Date:  2008-11-15       Impact factor: 6.860

8.  Trends in incidence of anal cancer in Denmark.

Authors:  M Frisch; M Melbye; H Møller
Journal:  BMJ       Date:  1993-02-13

9.  Benign anal lesions, inflammatory bowel disease and risk for high-risk human papillomavirus-positive and -negative anal carcinoma.

Authors:  M Frisch; B Glimelius; A J van den Brule; J Wohlfahrt; C J Meijer; J M Walboomers; H O Adami; M Melbye
Journal:  Br J Cancer       Date:  1998-12       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.